ArticleMedical journal, Armed Forces India
Genetic discovery in vesicoureteral reflux using exome sequencing: A pilot study.
Article in Medical journal, Armed Forces India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CAKUT: Current Understanding and Future Directions.Indian journal of pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vesicoureteral reflux (VUR) is a genetically heterogenous disorder. We conducted this pilot study to explore the possibility of genetic discovery in patients with VUR using exome sequencing. Methods: Whole exome sequencing was performed on the DNA of ten Indian children (nine boys) with bilateral grade IV/V reflux and bilateral renal hypodysplasia (extreme phenotype) as well as that of a family with 2 affected male siblings with bilateral VUR and chronic kidney disease. For prioritization of single nucleotide variations (SNVs) in the ten children with extreme phenotype, extremely rare and deleterious variations were selected from a list of 778 genes of biological relevance. Hypothesis-free prioritization was performed in the VUR family. Copy-number variations (CNV) were also called and prioritized from whole exome data. Results: Among ten patients with extreme phenotype, rare and novel and deleterious variants related to VUR and renal hypodysplasia were identified in 7/10 patients each. At least one prioritized variant in either genes related to VUR per se or renal hypodysplasia was seen in 8/10 patients. All patients carried different variations. Among the remaining two patients, one carried a pathogenic CNV. In the VUR family, a rare and deleterious variant in SLIT1 gene was identified. Conclusion: Sharp phenotyping in combination with exome sequencing using a combination of approaches including hypothesis-driven and hypothesis-free for prioritization of SNVs and study of CNVs seems to be an optimal method of genetic discovery of VUR. VUR is genetically heterogenous.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.